From: Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)
 | Baseline (N=7) | 6 months (N=6) | 12 months (N=4) |
---|---|---|---|
Number (%*) of patients in disease remission (physician assessment) | 4 (57.1) | 5 (83,3) | 3 (75.0) |
Physician Global Assessment, percentage of absent/mild-moderate/severe rating | 43 / 43 / 14 | 83 / 17 / 0 | 50 / 50 / 0 |
Patients´ assessment of current disease activity; 0–10, median (min; max) | 0 (0; 7) | 1.0 (0; 3) | 0.5 (0; 8) |
Patients´ assessment of current fatigue; 0–10, median (min; max) | 2.0 (0; 7) | 1.5 (0; 7) | 2.5 (0; 4) |
Number (%*) of patients without impairment of social life by the disease | 2 (40) | 4 (80) | 3 (100) |
Number (%*) of patients with days absent from work/school during last 6 months | 2 (29) | 3 (50) | 0 (0) |
CRP, median (mg/dl) | 0.2 | 0.5 | 0.3 |
SAA, median (mg/dl) | 0.6 | 0.9 | 0.8 |